Who may need Shingrix for shingles, and how many doses are given?
Shingrix is a non-live vaccine that helps prevent shingles and its complications; it does not treat an active episode. US guidance recommends two doses from age 50 and for immunocompromised adults from age 19. Confirm local eligibility, availability and timing with a clinician.
Details
Why immune status matters
Some conditions and treatments increase shingles risk, and the timing of immunosuppressive treatment can influence vaccination timing. Having had shingles does not remove the need to discuss vaccination, but the vaccine should not be used to treat the current episode.
Spacing the doses
US recommendations normally use an interval of two to six months. Selected immunocompromised patients may receive the second dose after one to two months under clinical guidance. If the second dose is late, do not automatically restart the series; ask the vaccination provider how to complete it.
What to expect afterwards
Arm soreness, fatigue or a temporary fever may occur. Report previous severe allergic reactions, pregnancy or an acute illness. The ages above describe US guidance and do not establish an identical Jordanian schedule. Local product availability and recommendations must guide the individual decision.
Related reading: Which vaccines may adults need, and how is the schedule chosen?.